Our mission is to bring lesser invasive medical devices to the cataract surgery global market. Devices that are in development include the WAVE Phaco, a low-cost advanced Phaco that will offer reusable tubing sets and a sub-sonic mechanical ultrasound function, and the CataPulse Enterprise, a novel technology that offers a significant patented alternative to Phaco that reduces critical cell loss, significantly reduces risk when performing cataract surgery on both eyes on the same surgical day, and will be the first cataract device approved for pediatric use. Stay tuned. We're doing some amazing things.